Healthcare
Oneview Healthcare PLC(ONVVF)
Live Price
Offline$0.16
+0.00% today
1Y Change
+0.00%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $90.00M
- Revenue Growth
- +20.6%
- EPS Growth
- -77.2%
- Dividend Yield
- 0.0%
Coverage: 251 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Oneview Healthcare PLC (ONVVF) is a Healthcare stock with a market cap of $90.00M and listed on OTC. The stock last traded around $0.16 and up 0.0% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +20.6%, EPS growth of -77.2%, a dividend yield of 0.0%. What stands out right now is revenue +20.6%, EPS -77.2%, free cash flow +20.4% with operating margin -92.1% and ROIC -188.1%. Valuation sits in the middle of the pack at price/sales 7.1. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ONVVF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+20.6% vs +7.6% peer median
Operating Margin
Below sector median
-92.1% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
2026 was reported on Feb 11, 2026 with an EPS surprise of +14.2% and a revenue surprise of -8.1%.
The operating picture looks softer than before
Revenue is at +20.6% and EPS is at -77.2%, with operating margin around -92.1%.
The next real check-in already has a date
The next earnings event is scheduled for Sep 1, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 11, 2026 | +14.2% | +0.0% | +0.0% | +0.0% |
2025 Feb 25, 2025 | +25.9% | +0.0% | +0.0% | +0.0% |
2024 Oct 28, 2024 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Edge
ONVVF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ONVVF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ONVVF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ONVVF and SPY.
Company Overview
Oneview Healthcare PLC
Other OTC
Oneview Healthcare PLC develops and sells software and related consultancy services for the healthcare sector in Ireland, the United States, Australia, Asia, and the Middle East. The company operates Care Experience Platform (CXP) Cloud Start that allows customers to implement critical digital engagement capabilities across their entire enterprise; CXP Cloud Enterprise, which gives patients and their families the ability to communicate virtually with healthcare teams along with access to education and health information; and CXP Enterprise On-Prem that meets enterprise needs across various types of facilities from new construction to existing hospitals with legacy wiring. It also provides empower patients and families, manage patient experience, deliver virtual care, digital door sign, and patient communication board solutions. The company was founded in 2008 and is based in Dublin, Ireland.
- Leadership
- James Fitter
- IPO Date
- Dec 16, 2020
- Employees
- 96
- Street Address
- Blackrock Business Park
- Mailing
- Dublin, A94 H2X4
- Region
- Dublin, IE
- Reporting Currency
- USD
- Investor Line
- 353 1 524 1677
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 7.1
- Price/Book
- 20.7
Growth
- Revenue
- +20.6%
- EPS
- -77.2%
- Free Cash Flow
- +20.4%
Profitability
- Gross Margin
- 61.8%
- Operating Margin
- -92.1%
- Net Margin
- -104.8%
- ROE
- -226.8%
- ROIC
- -188.1%
Balance Sheet
- Debt/Equity
- 0.55
- Current Ratio
- 1.30
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.